Search All News
Leading physician and researcher, Lisa Kachnic, MD, will lead Columbia's department of radiation oncology.
Anil Rustgi, the new director of the Herbert Irving Comprehensive Cancer Center, talks about new ideas in cancer research, the best patient care, and the importance of physician-scientists.
A clinical trial at Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.
- October 5, 2015
KEYTRUDA is an immunotherapy that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2, helping the immune system to help detect and fight cancer cells.
- September 23, 2015
The Columbia Combined Cancer Panel has been granted full approval by the New York State Department of Health.
- September 18, 2015
Dr. Naiyer Rizvi, director of thoracic oncology at CUMC, offers updates on immune checkpoint inhibitors in certain forms of lung cancers.
- May 26, 2015
Columbia scientists have created new decoy drugs that can intercept the deceptive growth signals that cancer cells send out.
- April 14, 2015
A study of the genomes of patients with a particularly aggressive form of non-Hodgkin’s lymphoma shows that many cases are driven by alterations in the JAK/STAT3 cell signaling pathway.
- March 26, 2015
Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine is changing the face of cancer research.
- March 19, 2015
At a special event at Columbia, oncologists and scientists will discuss how new research is changing the way cancer is being treated.
- March 16, 2015
At Columbia, every pediatric cancer patient’s tumor is sequenced, so personalized treatment may be considered.
- March 12, 2015
Advances in how the immune system can be harnessed to fight cancer offer new hope to patients with lung cancer.